Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

Bone Marrow Transplantation

Volumn 31, Issue 3, 2003, Pages 205-210

  Schulman, K A ^a   Stadtmauer, E A ^b   Reed, S D ^a   Glick, H A ^c   Goldstein, L J ^d   Pines, J M ^e   Jackman, J A ^e   Suzuki, S ^f   Styler, M J ^g   Crilley, P A ^g   Klumpp, T R ^h   Mangan, K F ^h   Glick, J H ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f URBAN INSTITUTE   (United States)

^g DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast neoplasms; Clinical trial; Comparative study; Cost and cost analysis; Female; Hematopoietic stem cell transplantation; Human; Neoplasm metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PACLITAXEL; THIOTEPA;

ADULT; ANEMIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DATA ANALYSIS; DIAGNOSTIC TEST; DRUG COST; DRUG MEGADOSE; ECONOMIC EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE COST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MEDICAL FEE; MEDICAL RECORD; MEDICARE; METASTASIS; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COHORT STUDIES; COSTS AND COST ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECONOMICS, HOSPITAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; STEM CELL TRANSPLANTATION; UNITED STATES;

EID: 0037295331     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703795     Document Type: Article

References (11)

1. Peters WP, Shpall EJ, Jones RB et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988; 6: 1368-1376.
2. Williams SF, Mick R, Desser R et al. High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. J Clin Oncol 1989; 7: 1824-1830.
3. Kennedy MJ, Beveridge RA, Rowley SD et al. High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst 1991; 83: 920-926.
4. Antman K, Ayash L, Elias A et al. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 1992; 10: 102-110.
5. Williams SF, Gilewski T, Mick R, Bitran JD. High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report. J Clin Oncol 1992; 10: 1743-1747.
6. Zujewski J, Nelson A, Abrams J. Much ado about not... enough data: high-dose chemotherapy with autologous stem cell rescue for breast cancer. J Natl Cancer Inst 1998; 90: 200-209.
7. Gaskin DJ, Kong J, Meropol NJ et al. Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model. Med Decis Making 1998; 18: 84-94.
8. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early stage breast cancer. N Engl J Med 1999; 340: 1733-1739.
9. Stadtmauer EA, O'Neill A, Goldstein LJ et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N Engl J Med 2000; 342: 1069-1076.
10. 1998 Drug Topics Red Book. Medical Economics Company, Inc: Montvale, NJ, 1998.
11. Stephenson J. Researchers struggle with trials of stem-cell transplants for breast cancer. JAMA 1997; 277: 1827-1829.